PEDIATRICS Vol. 54 No. 3 September 1974, pp. 282-288
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pierson, W. E.
Right arrow Articles by Kelley, V. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pierson, W. E.
Right arrow Articles by Kelley, V. C.

A Double-Blind Trial of Corticosteroid Therapy in Status Asthmaticus

William E. Pierson M.D.1, C. Warren Bierman M.D.1, and V. C. Kelley M.D. Ph.D.1

1 Pediatric Pulmonary Center, Children's Orthopedic Hospital and Medical Center, and Department of Pediatrics, University of Washington, Seattle

Initial treatment of status asthmaticus with corticosteroids caused significant improvement in arterial hypoxemia that did not occur in the control group. This improvement was not dependent upon changes in ventilatory function (FVC, FEV1). Betamethasone, hydrocortisone, and dexamethasone all appeared to have this beneficial effect. Both betamethasone and dexamethasone appeared to have the added advantage of higher unbound (pharmacologically active) corticosteroid levels. No toxic or adverse reactions were noted in this 24-hour study. Thus, corticosteroid therapy is indicated early in treatment of status asthmaticus, as withholding it needlessly exposes the patient to the risks of prolonged hypoxemia.

Submitted on January 21, 1974
Accepted on March 20, 1974




This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
G. J. RODRIGO and C. RODRIGO
CORTICOSTEROIDS IN ACUTE RESPIRATORY FUNCTION
Am. J. Respir. Crit. Care Med., April 1, 2000; 161(4): 1397 - 1398.
[Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. A. JANTZ and S. A. SAHN
Corticosteroids in Acute Respiratory Failure
Am. J. Respir. Crit. Care Med., October 1, 1999; 160(4): 1079 - 1100.
[Full Text]

Home page
 CLIN PEDIATRHome page
J. P. Bien, M. D. Bloom, R. L. Evans, B. Specker, and K. P. O'Brien
Intravenous Theophylline in Pediatric Status Asthmaticus: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial
Clinical Pediatrics, September 1, 1995; 34(9): 475 - 481.
[Abstract] [PDF]

Home page
 CLIN PEDIATRHome page
S. Press and R. S. Lipkind
A Treatment Protocol of the Acute Asthma Patient in a Pediatric Emergency Department
Clinical Pediatrics, October 1, 1991; 30(10): 573 - 577.
[Abstract] [PDF]

Home page
 CLIN PEDIATRHome page
H. I. Lecks
Appraisals of Cromolyn Sodium and Corticosteroids in the Treatment of the Asthmatic Child
Clinical Pediatrics, October 1, 1977; 16(10): 861 - 872.
[PDF]